2nd Symposium - Drug Discovery for Diseases of the Brain
21 October 2009
Following the success of the first symposium in 2008, the University of Sydney's Drug Discovery Research Unit, headed by Associate Professor Michael Kassiou, invite you to attend the 2nd Symposium on Drug Discovery for Diseases of the Brain at the Brain and Mind Research Institute.
27- 28 November 2009
Brain and Mind Research Institute
100 Mallett Street
Camperdown NSW
With diseases of the brain and mind accounting for 40% of all illnesses, drug discovery and innovation have an important role to play in improving treatment and prevention of Alzheimer's disease, depression, substance abuse and other mental illness.
The Symposium will bring together over 17 leading International and Australian experts in medicinal chemistry, drug discovery and development, as well as pharmaceutical industry representation. This fusion of science and industry will allow for the exchange of pioneering knowledge and ideas on disease prevention and enhanced treatment options.
Some of the presentations include:
Professor Richard A. Glennon - Virginia Commonwealth University USA
'Classification of Phenylalkylamines of Abuse Using Drug Discrimination Techniques'
Dr Heiko Wurdak - Scripps Research Institute, USA
'Small Molecules and Neural Stem Cells in Brain Physiology and Brain Cancer'
Professor Michael Parker - St. Vincent's Institute of Medical Research
'Structure-based drug discovery of molecules to combat Alzheimer's disease'
Professor Ronald Quinn - Eskitis Institute for Cell & Molecular Therapies
'Can you front-load for CNS penetration in natural product research?'
Download the symposium programfor details of other experts presenting.